Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Enzon Pharmaceuticals Inc. (ENZN) had Return on Equity of 25.86% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.03M |
|
$-0.50M |
|
-- |
|
$0.03M |
|
$1.35M |
|
$-1.33M |
|
$2.45M |
|
$1.12M |
|
$1.12M |
|
$0.78M |
|
$0.78M |
|
$0.78M |
|
$0.78M |
|
$-1.33M |
|
$-1.33M |
|
74.22M |
|
74.22M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$47.15M |
|
-- |
|
$0.02M |
|
$47.17M |
|
$1.68M |
|
-- |
|
-- |
|
$1.68M |
|
$3.01M |
|
$45.49M |
|
$45.49M |
|
74.22M |
|
| Cash Flow Statement Financials | |
$1.12M |
|
-- |
|
$-1.27M |
|
$47.01M |
|
$46.86M |
|
$-0.15M |
|
-- |
|
-- |
|
$-1.27M |
|
| Fundamental Metrics & Ratios | |
28.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-5103.85% |
|
-5103.85% |
|
-5103.85% |
|
4326.92% |
|
-1911.54% |
|
$1.12M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
25.86% |
1.71% |
|
1.65% |
|
1.71% |
|
$0.61 |
|
$0.02 |
|
$0.02 |
|